Morgan Stanley Upgrades Editas Medicine (EDIT) to Equalweight
Tweet Send to a Friend
(Updated - May 9, 2024 4:59 AM EDT)
Morgan Stanley analyst Matthew Harrison upgraded Editas Medicine (NASDAQ: EDIT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison upgraded Editas Medicine (NASDAQ: EDIT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
